MedTrace Logo

Novel Oral Anticoagulants in Stroke Patients

NCT02353585 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1050

Last updated 2022-12-22

No results posted yet for this study

Summary

The present study will monitor and explore acute neurovascular emergencies in patients treated with NOACs compared to those under treatment with VKAs. The primary aims of this study are: (1) To investigate characteristics, management and outcome of intracranial hemorrhage (ICH) in patients treated with NOAC compared to VKA. (2) To investigate the management and outcome of patients with acute ischaemic stroke under NOAC compared to VKA.

Conditions

Sponsors & Collaborators

  • Swiss Heart Foundation

    collaborator OTHER

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Stefan Engelter, MD · Neurology and Stroke Center

  • Philippe Lyrer, MD · Neurology and Stroke Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2021-03-31
Completion
2021-03-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02353585 on ClinicalTrials.gov